Details of the Drug Reposition

General Information of This Drug (ID: DMMPC6W)

Drug Name
CTL019   DMMPC6W
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 2 [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 2 [1]
------------------------------------------------------------------------------------
1 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute lymphoblastic leukaemia DIS87TGM 2A85 Clinical trial [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02445248) Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03601442) CTL019 Out of Specification MAP for ALL or DLBCL Patients